Alzheon

$6.3M revenue • 111 Speen St #306, Framingham, MA, 01701, United States

Last Updated Aug 8, 2025

Company Overview

Company Name

Alzheon

Address

111 Speen St #306, Framingham, MA, 01701, United States

Approx. Annual Revenue

$6.3M

About Alzheon

Alzheon is a biopharmaceutical company committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders. The company is headquartered in Framingham, Massachusetts, and its lead candidate, ALZ-801, is currently in phase 3 clinical trials as an oral anti-amyloid treatment with the potential to slow or stop the progression of Alzheimer's disease.

Frequently Asked Questions about Alzheon

Technologies Used

Social Profiles

Key Decision Makers

Luke Tolar Director, Business Development
LinkedIn
Audrey Rossow Senior Director, Clinical Operations
LinkedIn